Germany Limits Use of Oxford-AstraZeneca Vaccine Because of Fears of Blood Clots
Published
Federal health officials restrict recipients to 60 years old and older after 31 cases of blood clots were reported, including nine deaths
Full ArticlePublished
Federal health officials restrict recipients to 60 years old and older after 31 cases of blood clots were reported, including nine deaths
Full ArticleThe European Medicines Agency will conclude its investigation into possible rare side effects associated with AstraZeneca's..
The UK is "100% confident in the efficacy" of the Oxford-AstraZeneca coronavirus vaccine, after Germany suspended its use in the..